ALPHA TAU MEDICAL LTD (DRTS) Stock Income Statement
USA - NASDAQ:DRTS - IL0011839383 - Common Stock
3.714 USD
-0.15 (-3.93%)
3.75 USD
+0.04 (+0.97%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 37.52M | 36.04M | 35.68M | 32.14M | 13.79M | |||
| Research and Development | 27.89M | 27.02M | 26.42M | 20.89M | 11.45M | |||
| Selling, General, and Administrative Expenses | 9.63M | 9.02M | 9.71M | 11.25M | 2.34M | |||
| Operating Income | -37.52M | -36.04M | -35.68M | -32.14M | -13.79M | |||
| Interest Income/Expense | 2.48M | 4.08M | 4.54M | 2.20M | -200.00K | |||
| Other Income/Expense | null | 218.00K | 1.99M | -3.81M | -13.27M | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -35.04M | -31.74M | -29.14M | -33.74M | -27.26M | |||
| Income Tax | 166.00K | 6.00K | 16.00K | 20.00K | 10.00K | |||
| Net Income | -35.20M | -31.75M | -29.16M | -33.76M | -27.27M | |||
| EBITDA | null | -34.94M | -34.61M | -31.16M | -13.01M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.4831 | -0.454 | -0.4203 | -0.53 | -0.4 | |||
| Non GAAP EPS | -0.48 | -0.45 | -0.42 | -0.66 | null | |||
| Statistics | ||||||||
All data in USD